MacroGenics | MGNX - Market Capitalization

Stock Price
3.08
Daily Change
-0.02 -0.65%
Monthly
81.18%
Yearly
50.24%
Q1 Forecast
2.91

MacroGenics reported $193.5M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Genmab DKK 80.88B 7.82B Jun/2025
Geron USD 843M 31M Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
MacroGenics USD 106M 29M Sep/2025
Merck USD 261.26B 51.62B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Xencor USD 1.09B 256M Dec/2025